SCHEMBL10092186

SCHEMBL10092186

c1ccc(-n2c3ccccc3c3cc(-c4cccc(-c5cc(-n6c7ccccc7c7ccccc76)cc6c5oc5ccc(-n7c8ccccc8c8ccccc87)cc56)c4)ccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ATM Q13315 1/20 0.39
PLA2G2A P14555 4/20 0.36
PLA2G4A P47712 4/20 0.36
PLA2G10 O15496 1/20 0.36
ALOX5 P09917 1/20 0.34
PRKDC P78527 2/20 0.32
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
ALDH1A1 P00352 3/20 0.32
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
BRCA1 P38398 1/20 0.32
HSD17B10 Q99714 1/20 0.32
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31
TSPO P30536 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29343738 0.97 L3MBTL1 (0.40) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL5029869 0.96 KDM4E (0.43) L3MBTL1KDM4EATMALOX5SIRT2
SCHEMBL12925769 0.94 L3MBTL1 (0.44) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL22181960 0.92 ALOX5 (0.40) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL18265975 0.92 PLA2G2A (0.36) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL22181822 0.92 L3MBTL1 (0.42) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL22181826 0.92 L3MBTL1 (0.42) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL10092206 0.91 ALOX5 (0.39) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL12925798 0.91 ALOX5 (0.42) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL17280812 0.91 L3MBTL1 (0.41) L3MBTL1KDM4EATMPLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130119360-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME MERCK PATENT GMBH (DE) 2013-05-16 US disclosed
US-8367224-B2 Organic electroluminescence element, new compound for the same, display device and lighting device using the same KONICA MINOLTA HOLDINGS, INC. (JP) 2013-02-05 US disclosed
EP-2453496-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, NOVEL COMPOUND, LIGHTING DEVICE AND DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2012-05-16 EP disclosed
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2011-01-13 US disclosed
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME AOC2, AOC3, CDYL L3MBTL1 1475/4885KDM4E 367/4885ATM 3194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.